7-Methylxanthine
Appearance
Clinical data | |
---|---|
Other names | 7-MX; 7-Methylxanthin; Heteroxanthin; Heteroxanthine; NSC-7861 |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.008.200 |
Chemical and physical data | |
Formula | C6H6N4O2 |
Molar mass | 166.140 g·mol−1 |
3D model (JSmol) | |
| |
|
7-Methylxanthine (7-MX), also known as heteroxanthine, is an active metabolite of caffeine (1,3,7-trimethylxanthine) and theobromine (3,7-dimethylxanthine).[1][2] It is a non-selective antagonist of the adenosine receptors.[1][2] The compound may slow the progression of myopia (nearsightedness).[1][2] It is under investigation for this purpose in children with myopia.[1][2]
References
- ^ a b c d "7-Methylxanthine". Inxight Drugs. Retrieved 24 August 2022.
- ^ a b c d Singh H, Singh H, Latief U, Tung GK, Shahtaghi NR, Sahajpal NS, et al. (August 2022). "Myopia, its prevalence, current therapeutic strategy and recent developments: A Review". Indian Journal of Ophthalmology. 70 (8): 2788–2799. doi:10.4103/ijo.IJO_2415_21. PMID 35918918. S2CID 251281523.
{{cite journal}}
: CS1 maint: unflagged free DOI (link)